Posted by ABMN Staff on Apr 26th, 2024
BeiGene (NASDAQ:BGNE – Get Free Report) had its target price upped by equities research analysts at TD Cowen from $235.00 to $236.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a...
More of this article »